HHTM

MONTPELLIER, FRANCE — Sensorion announced that the independent Data Monitoring Committee (DMC) has identified no safety concerns and supports continued enrollment in the Audiogene Phase 1/2 clinical trial evaluating SENS-501, the company’s investigational gene therapy designed to treat a rare form of congenital deafness caused by mutations in the OTOF (otoferlin) gene. The committee’s review included favorable procedural tolerance and no

TAMPA, FLORIDA — HearUSA announced the launch of its Wonderful Sound for All initiative in partnership with the Hearing Aid Project (HAP), a program of Sertoma International, aimed at expanding access to hearing care for individuals facing financial barriers. Through the initiative, qualified individuals will be able to receive free hearing aids, hearing screenings, and audiology services at HearUSA hearing

The Cearvol Nano enters the OTC hearing aid market as an ultra-discreet in-the-canal (ITC) device designed for adults with mild to moderate hearing loss. Compact and subtle, it is positioned as a straightforward amplification solution for users who prefer physical controls over app-based adjustments. Company Background Cearvol is a newer entrant in the OTC hearing aid space, drawing on nearly

The Cearvol Wave Lite enters the OTC hearing aid market with a sleek, earbud-style design and a rechargeable battery. Targeted at adults with mild to moderately severe hearing loss, it aims to deliver smart amplification in a compact, affordable package—an appealing option for those exploring modern, direct-to-consumer hearing solutions. Company Background Cearvol is a newer entrant in the OTC hearing

DURHAM, NORTH CAROLINA – MED-EL USA announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for MED-EL cochlear implants for children seven months and older with bilateral sensorineural hearing loss (SNHL). This approval makes MED-EL’s cochlear implant system the first and only FDA-approved option for infants this young, enabling earlier access to sound and crucial stages

The National Acoustic Laboratories (NAL) has released a new video, The Making of the NAL-NL3 Fitting System, providing a behind-the-scenes look at how its latest hearing aid fitting system was created. NAL-NL3, launched on September 22, 2025, succeeds NAL-NL2 nearly 15 years after its release and is designed to reflect evolving clinical needs, advances in hearing technology, and changing expectations

SHAKOPEE, MINNESOTA – GN today celebrated the grand opening of its new North American headquarters in Shakopee, Minnesota. The 218,437-square-foot facility will serve as a regional operational center for all GN brands and as the U.S. headquarters for ReSound and Jabra Enhance hearing aids. Representatives from the City of Shakopee, the Shakopee Chamber of Commerce, Minnesota elected officials, former employees,

RESEARCH TRIANGLE PARK, N.C. — Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a specialty pharmaceutical company, today announced positive topline results from the investigator-initiated Phase 2/3 STS-J01 clinical trial evaluating PEDMARK® (sodium thiosulfate injection) for reducing cisplatin-induced ototoxicity in pediatric and adolescent and young adult (AYA) patients with non-metastatic solid tumors in Japan. PEDMARK® is the first and only U.S. Food

CHARLESTON, SOUTH CAROLINA — The Hearing Matters Podcast announced the launch of its new Thought Leader Coalition, bringing together three established figures in hearing healthcare: Dr. Gyl Kasewurm, Dr. Jasen A. Ruiz, and Madison Levine, B.C.-HIS. The initiative is designed to expand the podcast’s role as a resource for clinical education, patient engagement, and hearing-health innovation. The coalition will produce

A fully implantable cochlear implant isn’t just a technical milestone—it’s a fundamentally different way of living with hearing loss. In a candid conversation, Gael Hannan speaks with Michael Seufer, one of the first recipients of the Envoy Medical Acclaim, an investigational fully implanted cochlear implant that eliminates external hardware. Michael shares how his hearing loss, first identified in childhood, shaped